Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV001090637 | SCV001246295 | uncertain significance | not provided | 2020-01-01 | criteria provided, single submitter | clinical testing | |
Institute of Human Genetics, |
RCV001799732 | SCV002044341 | pathogenic | Intellectual developmental disorder 62 | 2021-12-21 | criteria provided, single submitter | research | |
Revvity Omics, |
RCV001090637 | SCV003834703 | uncertain significance | not provided | 2022-04-14 | criteria provided, single submitter | clinical testing | |
Tumer Group, |
RCV001799732 | SCV003915480 | pathogenic | Intellectual developmental disorder 62 | 2023-02-28 | criteria provided, single submitter | research | |
Gene |
RCV001090637 | SCV005874765 | pathogenic | not provided | 2024-08-30 | criteria provided, single submitter | clinical testing | Synonymous variant with RNA studies demonstrating this variant results in a deletion in the RNA transcript (r.1118_1212del) predicted to result in frameshift, p.(Glu373Glnfs*11) (PMID: 33597769); Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 33597769, 27535533, 38135915, 37525972) |